154 related articles for article (PubMed ID: 8143756)
1. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Jacquemin E; Dumont M; Mallet A; Erlinger S
Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Micheline D; Emmanuel J; Serge E
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295
[TBL] [Abstract][Full Text] [Related]
3. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
4. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
5. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
6. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
7. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
8. Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.
Galabert C; Montet JC; Lengrand D; Lecuire A; Sotta C; Figarella C; Chazalette JP
J Pediatr; 1992 Jul; 121(1):138-41. PubMed ID: 1352543
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat.
Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P
Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448
[TBL] [Abstract][Full Text] [Related]
10. Effects of iron overload on bile secretion and hepatic porphyrin metabolism in ethinyl estradiol-treated rats.
Cantoni L; Di Padova C; Rizzardini M; Dal Fiume D; Graziani A; Rovagnati P; Tritapepe R
Toxicology; 1986 Feb; 38(2):187-96. PubMed ID: 3945969
[TBL] [Abstract][Full Text] [Related]
11. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinyl estradiol in rats.
Bouchard G; Yousef IM; Tuchweber B
Toxicol Lett; 1994 Dec; 74(3):221-33. PubMed ID: 7871546
[TBL] [Abstract][Full Text] [Related]
12. Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.
Kinbara S; Ishizaki K; Sakakura H; Hirabayashi N; Kasai H; Araki T
Scand J Gastroenterol; 1997 Sep; 32(9):947-52. PubMed ID: 9299676
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
14. Biliary permeability during ethinyl estradiol-induced cholestasis studied by segmented retrograde intrabiliary injections in rats.
Iqbal S; Mills CO; Elias E
J Hepatol; 1985; 1(3):211-9. PubMed ID: 4067253
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets.
Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Favre CO; Rodríguez Garay EA; Mottino AD; Coleman R; Roma MG
Hepatology; 2001 Aug; 34(2):329-39. PubMed ID: 11481618
[TBL] [Abstract][Full Text] [Related]
16. Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat.
Hillstrom J; Duane WC; Eckfeldt JH; Furne J; Levitt MD
Proc Soc Exp Biol Med; 1992 May; 200(1):122-6. PubMed ID: 1570353
[TBL] [Abstract][Full Text] [Related]
17. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol modulates the gut microbiota of cholestasis in pregnant rats.
Li Z; Lei L; Ling L; Liu Y; Xiong Z; Shao Y
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193965
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
20. [Effect of estradiol and ethinyl estradiol on biliary bile acid excretion and bile flow].
Reimold WV; Holtermann M
Med Welt; 1982 Dec; 33(48):1744-8. PubMed ID: 7154929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
